Status:
NOT_YET_RECRUITING
Noncontrast CT-Based Deep Learning for Predicting Hematoma Expansion Risk in Patients with Spontaneous Intracerebral Hemorrhage
Lead Sponsor:
Qiang Yu
Collaborating Sponsors:
Xiangya Hospital of Central South University
The First Affiliated Hospital with Nanjing Medical University
Conditions:
Spontaneous Intracerebral Hemorrhage
Hematoma Expansion
Eligibility:
All Genders
18+ years
Brief Summary
Hematoma expansion is an independent predictor of poor prognosis and early neurological deterioration in patients with spontaneous intracerebral hemorrhage. Early identification of high-risk patients ...
Detailed Description
This project is planned to be implemented in four steps: 1\. Data Collection 1. Selection of Study Subjects: Clinical and imaging data of patients with spontaneous intracerebral hemorrhage were retr...
Eligibility Criteria
Inclusion
- Primary, spontaneous (non-traumatic) intracerebral hemorrhage (ICH).
- Age ≥ 18 years.
- Baseline CT performed within 24 hours of ICH symptom onset or last seen well (LSW).
- Follow-up CT within 72 hours.
Exclusion
- Secondary ICH caused by trauma, vascular anomalies (e.g., aneurysm, cavernous angioma, arteriovenous malformation), brain tumor, or hemorrhagic transformation in brain infarction.
- Primary intraventricular hemorrhage (IVH).
- Surgical treatment with external ventricular drain placement or craniotomy.
- Obvious artifacts observed in CT images.
Key Trial Info
Start Date :
September 25 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2024
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT06602115
Start Date
September 25 2024
End Date
December 1 2024
Last Update
September 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The First Affiliated Hospital of Chongqing Medical University
Chongqing, Chongqing Municipality, China, 400016